King's College London

Research portal

International Clinical Psychopharmacology, ‎0268-1315

Journal

  1. Body dysmorphic disorder: a treatment synthesis and consensus on behalf of the International College of Obsessive-Compulsive Spectrum Disorders and the Obsessive Compulsive and Related Disorders Network of the European College of Neuropsychopharmacology

    Castle, D., Beilharz, F., Phillips, K. A., Brakoulias, V., Drummond, L. M., Hollander, E., Ioannidis, K., Pallanti, S., Chamberlain, S. R., Rossell, S. L., Veale, D., Wilhelm, S., Van Ameringen, M., Dell'Osso, B., Menchon, J. M. & Fineberg, N. A., 20 Nov 2020, (E-pub ahead of print) In: International Clinical Psychopharmacology.

    Research output: Contribution to journalArticlepeer-review

  2. Low levels of serum vitamin D in clozapine-treated schizophrenia patients are associated with high levels of the proinflammatory cytokine IL-6

    Krivoy, A., Satz, J., Hornfeld, S. H., Bar, L., Gaughran, F., Shoval, G., Hochman, E., Weizman, A. & Taler, M., 6 Jan 2020, (E-pub ahead of print) In: International Clinical Psychopharmacology. p. 208-213 6 p.

    Research output: Contribution to journalArticlepeer-review

  3. Clozapine-associated neutropenia in Latin America: incidence report of 5380 Chilean users

    Mena, C. I., Nachar, R. A., Crossley, N. A. & González-Valderrama, A. A., 1 Sep 2019, In: International Clinical Psychopharmacology. 34, 5, p. 257-263 7 p.

    Research output: Contribution to journalArticlepeer-review

  4. Need to bleed? Clozapine haematological monitoring approaches a time for change

    Whiskey, E., Dzahini, O., Ramsay, R., O'Flynn, D., Mijovic, A., Gaughran, F., MacCabe, J., Shergill, S. & Taylor, D. M., 1 Sep 2019, In: International Clinical Psychopharmacology. 34, 5, p. 264-268 5 p.

    Research output: Contribution to journalArticlepeer-review

  5. Efficacy and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis

    Ostuzzi, G., Turrini, G., Gastaldon, C., Papola, D., Rayner, L., Caruso, R., Grassi, L., Hotopf, M. & Barbui, C., 1 Mar 2019, In: International Clinical Psychopharmacology. 34, 2, p. 65-75 11 p.

    Research output: Contribution to journalReview articlepeer-review

  6. Hyoscine for clozapine-induced hypersalivation: a double-blind, randomised, placebo-controlled crossover trial

    Segev, A., Evans, A., Hodsoll, J., Whiskey, E., Syed Sheriff, R., Shergill, S. S. & MacCabe, J. H., Mar 2019, In: International Clinical Psychopharmacology. 34, 2, p. 101–107 7 p.

    Research output: Contribution to journalArticlepeer-review

  7. Patient attitudes to clozapine initiation

    Gee, S. H., Shergill, S. S. & Taylor, D. M., Nov 2017, In: International Clinical Psychopharmacology. p. 337–342

    Research output: Contribution to journalArticlepeer-review

  8. Predictors of rehospitalization in a naturalistic cohort of patients with bipolar affective disorder

    O'Hagan, M., Cornelius, V., Young, A. H. & Taylor, D., May 2017, In: International Clinical Psychopharmacology. 32, 3, p. 115-120 5 p.

    Research output: Contribution to journalArticlepeer-review

  9. Gene polymorphisms potentially related to the pharmacokinetics of clozapine: a systematic review

    Krivoy, A., Gaughran, F., Weizman, A., Breen, G. & MacCabe, J. H., 2 Jan 2015, (E-pub ahead of print) In: International Clinical Psychopharmacology.

    Research output: Contribution to journalReview articlepeer-review

  10. Efficacy and safety of second-generation long-acting injections in schizophrenia: a meta-analysis of randomized-controlled trials

    Fusar-Poli, P., Kempton, M. J. & Rosenheck, R. A., Mar 2013, In: International Clinical Psychopharmacology. 28, 2, p. 57-66 10 p., N/A.

    Research output: Contribution to journalArticlepeer-review

  11. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia

    Rajkumar, A. P., Poonkuzhali, B., Kuruvilla, A., Jacob, M. & Jacob, K. S., Jan 2013, In: International Clinical Psychopharmacology. 28, 1, p. 50-6 7 p.

    Research output: Contribution to journalArticlepeer-review

  12. Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages?

    Nose, M., Tansella, M., Thornicroft, G., Schene, A., Becker, T., Veronese, A., Leese, M., Koeter, M., Angermeyer, M. & Barbui, C., Sep 2008, In: International Clinical Psychopharmacology. 23, 5, p. 287 - 290 4 p.

    Research output: Contribution to journalArticlepeer-review

  13. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania

    Yatham, L. N., Vieta, E., Young, A. H., Moller, H-J., Paulsson, B. & Vagero, M., Jul 2007, In: International Clinical Psychopharmacology. 22, 4, p. 212-220 9 p.

    Research output: Contribution to journalArticlepeer-review

  14. A controlled, mirror-image study of second-generation antipsychotics in the treatment of schizophrenia

    Taylor, D., Hayhurst, K. & Kerwin, R., May 2007, In: International Clinical Psychopharmacology. 22, 3, p. 133-6 4 p.

    Research output: Contribution to journalArticlepeer-review

  15. Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries

    Barbui, C., Nose, M., Mazzi, M. A., Thornicroft, G., Schene, A., Becker, T., Bindman, J., Leese, M., Helm, H., Koeter, M., Weinmann, S. & Tansella, M., Nov 2006, In: International Clinical Psychopharmacology. 21, 6, p. 355 - 362 8 p.

    Research output: Contribution to journalArticlepeer-review

  16. Quetiapine-induced myoclonus

    Velayudhan, L. & Kirchner, V., Mar 2005, In: International Clinical Psychopharmacology. 20, 2, p. 119-20 2 p.

    Research output: Contribution to journalArticlepeer-review

  17. Prognostic indicators for early discontinuation of risperidone long-acting injection

    Patel, MX., Young, C., Samele, C., Taylor, DM. & David, AS., Jul 2004, In: International Clinical Psychopharmacology. 19, 4, p. 233-239 7 p.

    Research output: Contribution to journalArticlepeer-review

  18. The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care

    Romeo, R., Patel, A., Knapp, M. & Thomas, C., May 2004, In: International Clinical Psychopharmacology. 19, 3, p. 125 - 134 10 p.

    Research output: Contribution to journalArticlepeer-review

  19. Risperidone and olanzapine in adults with intellectual disability: a clinical naturalistic study

    Bokszanska, A., Martin, G., Vanstraelen, M., Holt, G., Bouras, N. & Taylor, D., Sep 2003, In: International Clinical Psychopharmacology. 18, 5, p. 285-291 7 p.

    Research output: Contribution to journalArticlepeer-review

  20. Schizophrenia and bipolar disorder: similarities in pathogenic mechanisms but differences in neurodevelopment

    Walker, J., Curtis, V. & Murray, R. M., Aug 2002, In: International Clinical Psychopharmacology. 17, SUPPL. 3, p. S11 - S19

    Research output: Contribution to journalArticlepeer-review

  21. Options for pharmacological management of obesity in patients treated with atypical antipsychotics

    Werneke, U., Taylor, D. & Sanders, T. A. B., Jul 2002, In: International Clinical Psychopharmacology. 17, 4, p. 145 - 160 16 p.

    Research output: Contribution to journalLiterature reviewpeer-review

  22. Depot antipsychotic preparations in schizophrenia: the state of the economic evidence

    Knapp, M., Ilson, S. & David, A., 2002, In: International Clinical Psychopharmacology. 17, 3, p. 135 - 140 6 p.

    Research output: Contribution to journalArticlepeer-review

  23. The use of pharmacogenetics for prediction of antipsychotic response

    Arranz, M. J. & Kerwin, R. W., 2002, In: International Clinical Psychopharmacology. 17, p. S58 - S59

    Research output: Contribution to journalMeeting abstract

  24. A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review

    Whiskey, E., Werneke, U. & Taylor, D., Sep 2001, In: International Clinical Psychopharmacology. 16, 5, p. 239-52 14 p.

    Research output: Contribution to journalArticlepeer-review

  25. Atypical antipsychotics and hyperglycaemia

    Mir, S. & Taylor, D., Mar 2001, In: International Clinical Psychopharmacology. 16, 2, p. 63-73 11 p.

    Research output: Contribution to journalArticlepeer-review

  26. Healthy outcomes in schizophrenia - Introduction

    Murray, R. & Casey, D. E., 2001, In: International Clinical Psychopharmacology. 16, p. U4 - U4

    Research output: Contribution to journalEditorialpeer-review

  27. From pharmacological profiles to clinical outcomes

    Kerwin, R., 2000, In: International Clinical Psychopharmacology. 15, SUPPL. 4, p. S1 - S4

    Research output: Contribution to journalConference paper

  28. The effect of nefazodone on clozapine plasma concentrations

    Taylor, D., Bodani, M., Hubbeling, A. & Murray, R., May 1999, In: International Clinical Psychopharmacology. 14, 3, p. 185-7 3 p.

    Research output: Contribution to journalArticlepeer-review

  29. Antidepressant interactions with warfarin

    Duncan, D., Sayal, K., McConnell, H. & Taylor, D., Mar 1998, In: International Clinical Psychopharmacology. 13, 2, p. 87-94 8 p.

    Research output: Contribution to journalArticlepeer-review

  30. Co-administration of citalopram and clozapine: effect on plasma clozapine levels

    Taylor, D., Ellison, Z., Ementon Shaw, L., Wickham, H. & Murray, R., Jan 1998, In: International Clinical Psychopharmacology. 13, 1, p. 19-21 3 p.

    Research output: Contribution to journalArticlepeer-review

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454